Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart

Timothy R DeGrado, Michael R. Zalutsky, Ganesan Vaidyanathan

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

In order to clarify the uptake and retention mechanisms of radioiodinated meta-iodobenzylguanidine (MIBG) in heart, the kinetics of no-carrier-added [123I]MIBG were studied in the isolated working rat heart in interaction with pharmacologic agents. The tracer was administered in the perfusate as a 10-min pulse, followed by a 90-min washout period. Kinetic analysis of the externally monitored time-activity curves of control hearts showed avid uptake (Ki = 4.4 ± 0.7 mL/min/g), and monoexponential clearance (ko = 0.0056 ± 0.0017 l/min), indicating a distribution volume (Vd = Ki ko) of 834 ± 214 mL/g. Blocking experiments (n = 41) were performed with neuronal uptake (uptake-1) inhibitor desipramine (DMI; 50-100 nM) and the extraneuronal uptake (uptake-2) inhibitor N-(9-fluorenyl)-N-methyl-β-chloroethylamine (SKF550; 0.4-0.8 μM). Uptake rate was 27% reduced (P < 0.05) by 50 nM DMI but not significantly affected by 0.4 μM SKF550. Distribution volume was 88% reduced (P < 0.0005) by 50 nM DMI and 28% reduced (P < 0.05) by 0.4 μM SKF550. In DMI-blocked hearts, uptake rate was dramatically decreased (-80%, P < 0.0005) by SKF550 (0.4 μM), indicating uptake-2 transport contributed predominantly to the extraneuronal uptake of the tracer. The slow uptake rate seen with concomitant inhibition of uptake-1 and uptake-2 was further decreased by addition of unlabeled MIBG (1-10 μM) in a concentration-dependent manner, yet unaffected by addition of the vesicular uptake inhibitor Ro 4-1284 (1 μM). Thus, the uptake rate of [123I]MIBG is primarily dependent on uptake-1 and uptake-2 activity. Other possible mechanisms of uptake such as passive diffusion in association with intracellular binding are significant only in conditions where uptake-1 and uptake-2 mechanisms are largely inhibited.

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalNuclear Medicine and Biology
Volume22
Issue number1
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

3-Iodobenzylguanidine
2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo(a)quinolizin-2-ol
Desipramine
Pulse
Heart Rate

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart. / DeGrado, Timothy R; Zalutsky, Michael R.; Vaidyanathan, Ganesan.

In: Nuclear Medicine and Biology, Vol. 22, No. 1, 1995, p. 1-12.

Research output: Contribution to journalArticle

DeGrado, Timothy R ; Zalutsky, Michael R. ; Vaidyanathan, Ganesan. / Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart. In: Nuclear Medicine and Biology. 1995 ; Vol. 22, No. 1. pp. 1-12.
@article{19a0bc5e663a4d2880758c0298b71156,
title = "Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart",
abstract = "In order to clarify the uptake and retention mechanisms of radioiodinated meta-iodobenzylguanidine (MIBG) in heart, the kinetics of no-carrier-added [123I]MIBG were studied in the isolated working rat heart in interaction with pharmacologic agents. The tracer was administered in the perfusate as a 10-min pulse, followed by a 90-min washout period. Kinetic analysis of the externally monitored time-activity curves of control hearts showed avid uptake (Ki = 4.4 ± 0.7 mL/min/g), and monoexponential clearance (ko = 0.0056 ± 0.0017 l/min), indicating a distribution volume (Vd = Ki ko) of 834 ± 214 mL/g. Blocking experiments (n = 41) were performed with neuronal uptake (uptake-1) inhibitor desipramine (DMI; 50-100 nM) and the extraneuronal uptake (uptake-2) inhibitor N-(9-fluorenyl)-N-methyl-β-chloroethylamine (SKF550; 0.4-0.8 μM). Uptake rate was 27{\%} reduced (P < 0.05) by 50 nM DMI but not significantly affected by 0.4 μM SKF550. Distribution volume was 88{\%} reduced (P < 0.0005) by 50 nM DMI and 28{\%} reduced (P < 0.05) by 0.4 μM SKF550. In DMI-blocked hearts, uptake rate was dramatically decreased (-80{\%}, P < 0.0005) by SKF550 (0.4 μM), indicating uptake-2 transport contributed predominantly to the extraneuronal uptake of the tracer. The slow uptake rate seen with concomitant inhibition of uptake-1 and uptake-2 was further decreased by addition of unlabeled MIBG (1-10 μM) in a concentration-dependent manner, yet unaffected by addition of the vesicular uptake inhibitor Ro 4-1284 (1 μM). Thus, the uptake rate of [123I]MIBG is primarily dependent on uptake-1 and uptake-2 activity. Other possible mechanisms of uptake such as passive diffusion in association with intracellular binding are significant only in conditions where uptake-1 and uptake-2 mechanisms are largely inhibited.",
author = "DeGrado, {Timothy R} and Zalutsky, {Michael R.} and Ganesan Vaidyanathan",
year = "1995",
doi = "10.1016/0969-8051(94)00084-W",
language = "English (US)",
volume = "22",
pages = "1--12",
journal = "International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart

AU - DeGrado, Timothy R

AU - Zalutsky, Michael R.

AU - Vaidyanathan, Ganesan

PY - 1995

Y1 - 1995

N2 - In order to clarify the uptake and retention mechanisms of radioiodinated meta-iodobenzylguanidine (MIBG) in heart, the kinetics of no-carrier-added [123I]MIBG were studied in the isolated working rat heart in interaction with pharmacologic agents. The tracer was administered in the perfusate as a 10-min pulse, followed by a 90-min washout period. Kinetic analysis of the externally monitored time-activity curves of control hearts showed avid uptake (Ki = 4.4 ± 0.7 mL/min/g), and monoexponential clearance (ko = 0.0056 ± 0.0017 l/min), indicating a distribution volume (Vd = Ki ko) of 834 ± 214 mL/g. Blocking experiments (n = 41) were performed with neuronal uptake (uptake-1) inhibitor desipramine (DMI; 50-100 nM) and the extraneuronal uptake (uptake-2) inhibitor N-(9-fluorenyl)-N-methyl-β-chloroethylamine (SKF550; 0.4-0.8 μM). Uptake rate was 27% reduced (P < 0.05) by 50 nM DMI but not significantly affected by 0.4 μM SKF550. Distribution volume was 88% reduced (P < 0.0005) by 50 nM DMI and 28% reduced (P < 0.05) by 0.4 μM SKF550. In DMI-blocked hearts, uptake rate was dramatically decreased (-80%, P < 0.0005) by SKF550 (0.4 μM), indicating uptake-2 transport contributed predominantly to the extraneuronal uptake of the tracer. The slow uptake rate seen with concomitant inhibition of uptake-1 and uptake-2 was further decreased by addition of unlabeled MIBG (1-10 μM) in a concentration-dependent manner, yet unaffected by addition of the vesicular uptake inhibitor Ro 4-1284 (1 μM). Thus, the uptake rate of [123I]MIBG is primarily dependent on uptake-1 and uptake-2 activity. Other possible mechanisms of uptake such as passive diffusion in association with intracellular binding are significant only in conditions where uptake-1 and uptake-2 mechanisms are largely inhibited.

AB - In order to clarify the uptake and retention mechanisms of radioiodinated meta-iodobenzylguanidine (MIBG) in heart, the kinetics of no-carrier-added [123I]MIBG were studied in the isolated working rat heart in interaction with pharmacologic agents. The tracer was administered in the perfusate as a 10-min pulse, followed by a 90-min washout period. Kinetic analysis of the externally monitored time-activity curves of control hearts showed avid uptake (Ki = 4.4 ± 0.7 mL/min/g), and monoexponential clearance (ko = 0.0056 ± 0.0017 l/min), indicating a distribution volume (Vd = Ki ko) of 834 ± 214 mL/g. Blocking experiments (n = 41) were performed with neuronal uptake (uptake-1) inhibitor desipramine (DMI; 50-100 nM) and the extraneuronal uptake (uptake-2) inhibitor N-(9-fluorenyl)-N-methyl-β-chloroethylamine (SKF550; 0.4-0.8 μM). Uptake rate was 27% reduced (P < 0.05) by 50 nM DMI but not significantly affected by 0.4 μM SKF550. Distribution volume was 88% reduced (P < 0.0005) by 50 nM DMI and 28% reduced (P < 0.05) by 0.4 μM SKF550. In DMI-blocked hearts, uptake rate was dramatically decreased (-80%, P < 0.0005) by SKF550 (0.4 μM), indicating uptake-2 transport contributed predominantly to the extraneuronal uptake of the tracer. The slow uptake rate seen with concomitant inhibition of uptake-1 and uptake-2 was further decreased by addition of unlabeled MIBG (1-10 μM) in a concentration-dependent manner, yet unaffected by addition of the vesicular uptake inhibitor Ro 4-1284 (1 μM). Thus, the uptake rate of [123I]MIBG is primarily dependent on uptake-1 and uptake-2 activity. Other possible mechanisms of uptake such as passive diffusion in association with intracellular binding are significant only in conditions where uptake-1 and uptake-2 mechanisms are largely inhibited.

UR - http://www.scopus.com/inward/record.url?scp=0028893627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028893627&partnerID=8YFLogxK

U2 - 10.1016/0969-8051(94)00084-W

DO - 10.1016/0969-8051(94)00084-W

M3 - Article

C2 - 7735158

AN - SCOPUS:0028893627

VL - 22

SP - 1

EP - 12

JO - International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology

JF - International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology

SN - 0969-8051

IS - 1

ER -